Rexford Industrial Realty Inc
Change company Symbol lookup
Select an option...
REXR-A Rexford Industrial Realty Inc
DPW DPW Holdings Inc
IWN iShares Russell 2000 Value ETF
XNXCX Nuveen California Select Tax-Free Income Portfolio
AMGN Amgen Inc
AMSC American Superconductor Corp
CVBF CVB Financial Corp
PHG Koninklijke Philips NV
IVR Invesco Mortgage Capital Inc
CORE Core-Mark Holding Company Inc
Go

Real Estate : Equity Real Estate Investment Trusts (REITs) | Small Cap Growth
Company profile

Rexford Industrial Realty, Inc. is a self-administered and self-managed real estate investment trust (REIT). The Company is focused on owning and operating industrial properties in Southern California infill markets. Through its controlling interest in its Rexford Industrial Realty, L.P. (Operating Partnership) and its subsidiaries, it owns, manages, leases, acquires and develops industrial real estate principally located in Southern California infill markets, and, from time to time, acquire or provide mortgage debt secured by industrial property. It owns a portfolio of approximately 236 properties with approximately 29.9 million rentable square feet. In addition, it manages approximately 20 properties with approximately one million rentable square feet.

This security is a preferred stock
Closing Price
$25.22
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
0

10-day average volume:
19,621
0

LAWSUITS FILED AGAINST NXTC, MESO and LVS - Jakubowitz Law Pursues Shareholders Claims

5:52 pm ET November 18, 2020 (Accesswire) Print

NEW YORK, NY / ACCESSWIRE / November 18, 2020 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who purchased shares within the class periods listed below. Shareholders interested in representing the class of wronged shareholders have until the lead plaintiff deadline to petition the court. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. For more details and to speak with our firm without cost or obligation, follow the links below.

Nextcure, Inc. (NASDAQ:NXTC)

CONTACT JAKUBOWITZ ABOUT NXTC:https://claimyourloss.com/securities/nextcure-inc-loss-submission-form/?id=11049&from=1

The Nextcure lawsuit was filed on behalf of investors who purchased Nextcure, Inc. (NASDAQ: NXTC) securities: (1) between November 5, 2019 and July 14, 2020, inclusive; and/or (2) pursuant or traceable to the company's secondary public offering declared effective on November 14, 2019.

Lead Plaintiff Deadline : November 20, 2020

Throughout the class period defendants' statements were materially misleading because the data Defendants possessed on its principle product candidate, NC318, showed a lack of efficacy and objective responses. Had the truth been revealed, the market would have seen that NC318 was not, in fact, effective in treating most tumor types, that the NC318 application was proving to be limited (if even useful at all), and, as a result, there was a significant realizable risk that NC318 would not be nearly as popular as then-existing blockbuster drugs, such as Keytruda.

Mesoblast Limited (NASDAQ:MESO)

CONTACT JAKUBOWITZ ABOUT MESO:https://claimyourloss.com/securities/mesoblast-limited-loss-submission-form/?id=11049&from=1

Class Period : April 16, 2019 - October 1, 2020

Lead Plaintiff Deadline : December 7, 2020

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) comparative analyses between Mesoblast's Phase 3 trial and three historical studies did not support the effectiveness of the Company's lead product candidate, remestemcel-L, for steroid refractory acute graft versus host disease due to design differences between the four studies; (2) as a result, the US Food and Drug Administration was reasonably likely to require further clinical studies; (3) as a result, the commercialization of remestemcel-L in the U.S. was likely to be delayed; and (4) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Las Vegas Sands Corp. (NYSE:LVS)

CONTACT JAKUBOWITZ ABOUT LVS:https://claimyourloss.com/securities/las-vegas-sands-corp-loss-submission-form/?id=11049&from=1

Class Period : February 27, 2016 - September 15, 2020

Lead Plaintiff Deadline : December 21, 2020

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) weaknesses existed in Marina Bay Sands' casino control measures pertaining to fund transfers; (ii) the Marina Bay Sands' casino was consequently prone to illicit fund transfers that implicated, among other issues, the transfer of customer funds to unauthorized persons and potential breaches in the Company's anti-money laundering procedures; (iii) the foregoing foreseeably increased the risk of litigation against the Company, as well as investigation and increased oversight by regulatory authorities; (iv) Las Vegas Sands had inadequate disclosure controls and procedures; (v) consequently, all the foregoing issues were untimely disclosed; and (vi) as a result, the Company's public statements were materially false and misleading at all relevant times.

Jakubowitz Law is vigorous in pursuit of justice for shareholders who have been the victim of securities fraud. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:Jakubowitz Law1140 Avenue of the Americas9th FloorNew York, New York 10036T: (212) 867-4490F: (212) 537-5887

SOURCE: Jakubowitz Law

View source version on accesswire.com: https://www.accesswire.com/617445/LAWSUITS-FILED-AGAINST-NXTC-MESO-and-LVS--Jakubowitz-Law-Pursues-Shareholders-Claims

comtex tracking

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.